Latest updates

NML to enhance pandemic preparedness in a strategic partnership with The Pandemic Institute

News - The National Measurement Laboratory (NML) at LGC signs collaborative partnership with The Pandemic Institute aimed at enhancing pandemic preparedness. Combining expertise together to ensure scientific readiness for future pandemics.

28 June 2024
Ensuring accuracy in the development and application of nucleic acid amplification tests (NAATs) for infectious disease

News - During COVID-19, bioanalytical diagnostic techniques (like PCR and lateral flow tests) were widely discussed across the world. This paper discusses learnings from the COVID-19 pandemic and offers alternative approaches to conventional diagnostic evaluations for infectious disease to improve diagnostic performance assessment and meet increased regulatory requirements.

21 June 2024
Celebrating sustainable measurement on World Metrology Day

News - World Metrology Day is the annual celebration of the signature of the Metre Convention on 20 May 1875. The National Measurement Laboratory (NML) at LGC provides measurement research and services to improve accuracy, traceability and standardisation of chemical and biological measurements.

20 May 2024
The National Measurement Laboratory (NML) at LGC appoint Academic in Residence at Strathclyde

News - The National Measurement Laboratory (NML) at LGC recently appointed their second Academic in Residence, Dr Zahra Rattray, based at the NML’s Centre for Advanced Measurement Research and Health Translation at the University of Strathclyde.

23 April 2024
Pioneering Cancer Treatments through Enhanced Genomic Profiling

News - Pioneering Cancer Treatments through Enhanced Genomic Profiling in the GenomeMET Project.

22 February 2024
NML collaborate to improve quality assessment schemes for Chronic Myeloid Leukaemia Minimal Residual Disease testing

News - The National Measurement Laboratory and UK NEQAS for Leucocyte Immunophenotyping announce collaboration to improve quality assessment schemes for Chronic Myeloid Leukaemia Minimal Residual Disease testing.

25 January 2024